A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer | Zendy

HsuanYu Chen | Zendy; SungLiang Yu | Zendy; ChunHouh Chen | Zendy; GeeChen Chang | Zendy; ChihYi Chen | Zendy; Ang Yuan | Zendy; Chiou-Ling Cheng | Zendy; Chien-Hsun Wang | Zendy; Harn-Jing Terng | Zendy; Shu-Fang Kao | Zendy; WingKai Chan | Zendy; Han-Ni Li | Zendy; Chun-Chi Liu | Zendy; Sher Singh | Zendy; Wei J. Chen | Zendy; Jeremy J.W. Chen | Zendy; PanChyr Yang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer

Author(s) -

HsuanYu Chen,

SungLiang Yu,

ChunHouh Chen,

GeeChen Chang,

ChihYi Chen,

Ang Yuan,

Chiou-Ling Cheng,

Chien-Hsun Wang,

Harn-Jing Terng,

Shu-Fang Kao,

WingKai Chan,

Han-Ni Li,

Chun-Chi Liu,

Sher Singh,

Wei J. Chen,

Jeremy J.W. Chen,

PanChyr Yang

Publication year - 2007

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa060096

Subject(s) - medicine , lung cancer , oncology , gene signature , survival analysis , microarray analysis techniques , gene expression profiling , microarray , proportional hazards model , gene expression , bioinformatics , gene , biology , genetics

Current staging methods are inadequate for predicting the outcome of treatment of non-small-cell lung cancer (NSCLC). We developed a five-gene signature that is closely associated with survival of patients with NSCLC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research